ONTOLOGY REPORT - ANNOTATIONS
| Term: | mifepristone |
|
| Accession: | CHEBI:50692
|
browse the term
|
| Definition: | A 3-oxo steroid that has formula C29H35NO2. |
| Synonyms: | exact_synonym: | 11beta-[4-(dimethylamino)phenyl]-17beta-hydroxy-17alpha-(prop-1-yn-1-yl)estra-4,9-dien-3-one |
| | related_synonym: | 11-(4-DIMETHYLAMINO-PHENYL)-17-HYDROXY-13-METHYL-17-PROP-1-YNYL-1,2,6,7,8,11,12,13,14,15,16,17-DODEC AHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE; C29H35NO2; InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1; InChIKey=VKHAHZOOUSRJNA-GCNJZUOMSA-N; Mifegyne; Mifeprex; RU-486; RU486; [H][C@@]12CCC3=CC(=O)CCC3=C1[C@H](C[C@@]1(C)[C@@]2([H])CC[C@@]1(O)C#CC)c1ccc(cc1)N(C)C; mifepristona; mifepristonum |
| | alt_id: | CHEBI:40057; CHEBI:6934 |
| | xref_casrn: | 84371-65-3 |
| | xref: | ChEMBL:812273 "ChEMBL COMPOUND"; ChemIDplus:84371-65-3 "CAS Registry Number"; DrugBank:DB00834 "DrugBank"; KEGG COMPOUND:84371-65-3 "CAS Registry Number"; KEGG COMPOUND:C07652 "KEGG COMPOUND"; KEGG DRUG:D00585 "KEGG DRUG" |
| | xref_mesh: | MESH:D015735 |
| | xref: | PDBeChem:486 "PDBeChem"; Patent:EP57115 "Patent"; Patent:US4386085 "Patent" |
|
|
mifepristone
|
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
decreases expression |
ISO |
1 |
96,622,574 |
96,703,723 |
RGD:6480464 |
CTD |
| G |
Ablim1 |
actin-binding LIM protein 1 |
|
increases expression |
ISO |
1 |
263,380,818 |
263,465,905 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
multiple interactions |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
increases expression |
ISO |
10 |
89,420,934 |
89,471,398 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
decreases expression |
ISO |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
multiple interactions |
ISO |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
multiple interactions |
ISO |
4 |
155,664,035 |
155,677,627 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
|
increases expression |
ISO |
2 |
230,142,679 |
230,166,226 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh3b2 |
aldehyde dehydrogenase 3 family, member B2 |
|
decreases expression |
ISO |
1 |
206,549,529 |
206,553,424 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
decreases expression |
ISO |
10 |
64,308,826 |
64,312,415 |
RGD:6480464 |
CTD |
| G |
Ankrd10 |
ankyrin repeat domain 10 |
|
increases expression |
ISO |
16 |
82,719,075 |
82,742,218 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
decreases expression |
ISO |
1 |
135,600,751 |
135,619,208 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
multiple interactions |
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
increases expression |
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Apoc1 |
apolipoprotein C-I |
|
decreases expression |
ISO |
1 |
78,996,677 |
78,999,960 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects binding |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases activity |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Araf |
v-raf murine sarcoma 3611 viral oncogene homolog |
|
multiple interactions |
ISO |
X |
12,556,904 |
12,568,583 |
RGD:6480464 |
CTD |
| G |
Arhgap28 |
Rho GTPase activating protein 28 |
|
increases expression |
ISO |
9 |
106,996,258 |
107,162,388 |
RGD:6480464 |
CTD |
| G |
Arl4d |
ADP-ribosylation factor-like 4D |
|
decreases expression |
ISO |
10 |
90,700,469 |
90,702,625 |
RGD:6480464 |
CTD |
| G |
Arl6ip1 |
ADP-ribosylation factor-like 6 interacting protein 1 |
|
increases expression |
ISO |
1 |
176,332,729 |
176,342,244 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
multiple interactions |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Axin2 |
axin 2 |
|
increases expression |
ISO |
10 |
98,294,466 |
98,321,830 |
RGD:6480464 |
CTD |
| G |
B3gat3 |
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
|
decreases expression |
ISO |
1 |
211,597,624 |
211,604,142 |
RGD:6480464 |
CTD |
| G |
B3gnt6 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase) |
|
decreases expression |
ISO |
1 |
155,435,459 |
155,440,490 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects localization |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcat2 |
branched chain amino acid transaminase 2, mitochondrial |
|
decreases expression |
ISO |
1 |
96,038,287 |
96,055,622 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
increases expression |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bnip2 |
BCL2/adenovirus E1B interacting protein 2 |
|
increases expression |
ISO |
8 |
74,421,904 |
74,435,300 |
RGD:6480464 |
CTD |
| G |
Bscl2 |
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
|
decreases expression |
ISO |
1 |
211,509,675 |
211,518,963 |
RGD:6480464 |
CTD |
| G |
Btk |
Bruton agammaglobulinemia tyrosine kinase |
|
increases expression |
ISO |
X |
121,998,935 |
122,030,289 |
RGD:6480464 |
CTD |
| G |
C1qtnf6 |
C1q and tumor necrosis factor related protein 6 |
|
increases expression |
ISO |
7 |
116,479,791 |
116,486,309 |
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cabin1 |
calcineurin binding protein 1 |
|
increases expression |
ISO |
20 |
13,444,801 |
13,569,453 |
RGD:6480464 |
CTD |
| G |
Camp |
cathelicidin antimicrobial peptide |
|
decreases expression |
ISO |
8 |
114,214,914 |
114,216,728 |
RGD:6480464 |
CTD |
| G |
Capn5 |
calpain 5 |
|
decreases expression |
ISO |
1 |
155,366,678 |
155,421,183 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
decreases expression |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Cd28 |
Cd28 molecule |
|
multiple interactions |
ISO |
9 |
59,342,273 |
59,367,743 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
decreases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd4 |
Cd4 molecule |
|
multiple interactions |
ISO |
4 |
160,988,512 |
161,014,038 |
RGD:6480464 |
CTD |
| G |
Cd4 |
Cd4 molecule |
|
decreases expression |
ISO |
4 |
160,988,512 |
161,014,038 |
RGD:6480464 |
CTD |
| G |
Cd69 |
Cd69 molecule |
|
increases expression |
ISO |
4 |
166,527,683 |
166,535,601 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
multiple interactions |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
increases expression |
ISO |
19 |
2,225,209 |
2,382,805 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
multiple interactions |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
multiple interactions |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
multiple interactions |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
decreases expression |
ISO |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
|
increases expression |
ISO |
8 |
119,149,810 |
119,165,515 |
RGD:6480464 |
CTD |
| G |
Cntnap1 |
contactin associated protein 1 |
|
decreases expression |
ISO |
10 |
90,185,756 |
90,210,837 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
decreases expression |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col4a5 |
collagen, type IV, alpha 5 |
|
decreases expression |
ISO |
X |
36,918,697 |
37,130,659 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
multiple interactions |
ISO |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Cpz |
carboxypeptidase Z |
|
increases expression |
ISO |
14 |
80,857,371 |
80,880,592 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
multiple interactions |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
|
decreases expression |
ISO |
19 |
50,313,710 |
50,378,031 |
RGD:6480464 |
CTD |
| G |
Cst7 |
cystatin F (leukocystatin) |
|
decreases expression |
ISO |
3 |
141,188,442 |
141,199,756 |
RGD:6480464 |
CTD |
| G |
Ctnnal1 |
catenin (cadherin associated protein), alpha-like 1 |
|
increases expression |
ISO |
5 |
74,716,087 |
74,771,424 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
increases expression |
ISO |
19 |
10,666,940 |
10,676,424 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
decreases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
increases expression |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl13 |
chemokine (C-X-C motif) ligand 13 |
|
decreases expression |
ISO |
14 |
15,126,332 |
15,131,368 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
ISO |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cxcr7 |
chemokine (C-X-C motif) receptor 7 |
|
decreases expression |
ISO |
9 |
89,343,528 |
89,355,053 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
multiple interactions |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
increases expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
5 |
135,917,327 |
135,934,636 |
RGD:6480464 |
CTD |
| G |
Dcn |
decorin |
|
increases expression |
ISO |
7 |
35,004,234 |
35,045,191 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
decreases expression |
ISO |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
multiple interactions |
EXP |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
|
multiple interactions |
ISO |
5 |
163,341,856 |
163,375,604 |
RGD:6480464 |
CTD |
| G |
Dio2 |
deiodinase, iodothyronine, type II |
|
increases expression |
ISO |
6 |
114,307,758 |
114,317,563 |
RGD:6480464 |
CTD |
| G |
Dio2 |
deiodinase, iodothyronine, type II |
|
multiple interactions |
EXP |
6 |
114,307,758 |
114,317,563 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf 1 homolog (Xenopus laevis) |
|
multiple interactions |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf 1 homolog (Xenopus laevis) |
|
multiple interactions |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf 1 homolog (Xenopus laevis) |
|
multiple interactions |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dlc1 |
deleted in liver cancer 1 |
|
multiple interactions |
ISO |
16 |
59,312,930 |
59,355,129 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
increases expression |
ISO |
6 |
63,583,033 |
63,587,247 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
decreases expression |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
increases expression |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
increases expression |
ISO |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
|
increases expression |
ISO |
9 |
108,303,607 |
108,426,942 |
RGD:6480464 |
CTD |
| G |
Esm1 |
endothelial cell-specific molecule 1 |
|
increases expression |
ISO |
2 |
44,626,010 |
44,634,748 |
RGD:6480464 |
CTD |
| G |
Exosc5 |
exosome component 5 |
|
decreases expression |
ISO |
1 |
80,871,353 |
80,876,329 |
RGD:6480464 |
CTD |
| G |
F13a1 |
coagulation factor XIII, A1 polypeptide |
|
increases expression |
ISO |
17 |
34,093,525 |
34,270,498 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
multiple interactions |
EXP |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
multiple interactions |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
Fah |
fumarylacetoacetate hydrolase |
|
decreases expression |
ISO |
1 |
140,851,975 |
140,876,187 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fbln1 |
fibulin 1 |
|
multiple interactions |
ISO |
7 |
123,208,154 |
123,287,289 |
RGD:6480464 |
CTD |
| G |
Fbln1 |
fibulin 1 |
|
decreases expression |
ISO |
7 |
123,208,154 |
123,287,289 |
RGD:6480464 |
CTD |
| G |
Fbxo46 |
F-box protein 46 |
|
decreases expression |
ISO |
1 |
78,480,914 |
78,497,104 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
multiple interactions |
ISO |
20 |
6,637,478 |
6,686,768 |
RGD:6480464 |
CTD |
| G |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
|
decreases expression |
ISO |
6 |
119,569,366 |
119,658,949 |
RGD:6480464 |
CTD |
| G |
Foxn3 |
forkhead box N3 |
|
increases expression |
ISO |
6 |
123,385,156 |
123,762,322 |
RGD:6480464 |
CTD |
| G |
Foxo3 |
forkhead box O3 |
|
multiple interactions |
ISO |
20 |
46,171,784 |
46,262,818 |
RGD:6480464 |
CTD |
| G |
Foxq1 |
forkhead box Q1 |
|
multiple interactions |
EXP |
17 |
39,332,906 |
39,334,655 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
multiple interactions |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fstl3 |
follistatin-like 3 (secreted glycoprotein) |
|
decreases expression |
ISO |
7 |
11,438,360 |
11,442,885 |
RGD:6480464 |
CTD |
| G |
Fzd10 |
frizzled family receptor 10 |
|
increases expression |
ISO |
12 |
29,164,632 |
29,166,832 |
RGD:6480464 |
CTD |
| G |
Fzd4 |
frizzled family receptor 4 |
|
increases expression |
ISO |
1 |
145,953,743 |
145,957,666 |
RGD:6480464 |
CTD |
| G |
Fzd6 |
frizzled family receptor 6 |
|
increases expression |
ISO |
7 |
74,562,307 |
74,594,014 |
RGD:6480464 |
CTD |
| G |
Fzd9 |
frizzled family receptor 9 |
|
increases expression |
ISO |
12 |
22,581,510 |
22,583,824 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
multiple interactions |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Ggta1 |
glycoprotein, alpha-galactosyltransferase 1 |
|
multiple interactions |
ISO |
3 |
14,485,028 |
14,559,484 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gmppa |
GDP-mannose pyrophosphorylase A |
|
decreases expression |
ISO |
9 |
74,713,604 |
74,721,031 |
RGD:6480464 |
CTD |
| G |
Gpr56 |
G protein-coupled receptor 56 |
|
decreases expression |
ISO |
19 |
10,438,332 |
10,475,607 |
RGD:6480464 |
CTD |
| G |
Grb2 |
growth factor receptor bound protein 2 |
|
multiple interactions |
ISO |
10 |
105,722,014 |
105,818,649 |
RGD:6480464 |
CTD |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA 1 |
|
decreases expression |
ISO |
10 |
42,613,359 |
42,616,610 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
increases expression |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
multiple interactions |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gstt2 |
glutathione S-transferase, theta 2 |
|
decreases expression |
ISO |
20 |
13,221,696 |
13,225,367 |
RGD:6480464 |
CTD |
| G |
Hdac2 |
histone deacetylase 2 |
|
increases expression |
ISO |
20 |
41,162,093 |
41,186,492 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
multiple interactions |
ISO |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hpgd |
hydroxyprostaglandin dehydrogenase 15 (NAD) |
|
multiple interactions |
ISO |
16 |
37,419,901 |
37,457,896 |
RGD:6480464 |
CTD |
| G |
Hpgd |
hydroxyprostaglandin dehydrogenase 15 (NAD) |
|
decreases expression |
ISO |
16 |
37,419,901 |
37,457,896 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
multiple interactions |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
multiple interactions |
ISO |
13 |
109,063,491 |
109,089,468 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
multiple interactions |
ISO |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
increases expression |
ISO |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsd17b6 |
hydroxysteroid (17-beta) dehydrogenase 6 |
|
decreases expression |
ISO |
7 |
1,118,183 |
1,137,670 |
RGD:6480464 |
CTD |
| G |
Hsd17b8 |
hydroxysteroid (17-beta) dehydrogenase 8 |
|
decreases expression |
ISO |
20 |
4,964,860 |
4,966,855 |
RGD:6480464 |
CTD |
| G |
Htr2b |
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
|
increases expression |
ISO |
9 |
84,840,026 |
84,852,984 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
decreases expression |
ISO |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il13ra2 |
interleukin 13 receptor, alpha 2 |
|
increases expression |
ISO |
X |
30,505,850 |
30,533,002 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
multiple interactions |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
multiple interactions |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
multiple interactions |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
increases expression |
ISO |
17 |
57,244,466 |
57,257,531 |
RGD:6480464 |
CTD |
| G |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
|
decreases expression |
ISO |
4 |
149,543,029 |
149,599,463 |
RGD:6480464 |
CTD |
| G |
Irak4 |
interleukin-1 receptor-associated kinase 4 |
|
decreases expression |
ISO |
7 |
133,055,185 |
133,081,614 |
RGD:6480464 |
CTD |
| G |
Itga6 |
integrin, alpha 6 |
|
increases expression |
ISO |
3 |
54,202,931 |
54,272,803 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Kdelr2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kif27 |
kinesin family member 27 |
|
increases expression |
ISO |
17 |
12,230,381 |
12,301,010 |
RGD:6480464 |
CTD |
| G |
Klhl6 |
kelch-like family member 6 |
|
increases expression |
ISO |
11 |
83,221,776 |
83,260,528 |
RGD:6480464 |
CTD |
| G |
Kmt2d |
lysine (K)-specific methyltransferase 2D |
|
decreases expression |
ISO |
7 |
137,601,739 |
137,639,556 |
RGD:6480464 |
CTD |
| G |
Lama2 |
laminin, alpha 2 |
|
decreases expression |
ISO |
1 |
18,203,466 |
18,885,462 |
RGD:6480464 |
CTD |
| G |
Lama3 |
laminin, alpha 3 |
|
decreases expression |
ISO |
18 |
4,030,463 |
4,121,355 |
RGD:6480464 |
CTD |
| G |
Lamc2 |
laminin, gamma 2 |
|
increases expression |
ISO |
13 |
68,151,074 |
68,211,117 |
RGD:6480464 |
CTD |
| G |
Ldoc1 |
leucine zipper, down-regulated in cancer 1 |
|
decreases expression |
ISO |
X |
147,294,439 |
147,294,882 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
increases secretion |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
|
decreases expression |
ISO |
4 |
148,071,431 |
148,130,313 |
RGD:6480464 |
CTD |
| G |
LOC100360920 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
increases expression |
ISO |
12 |
11,498,420 |
11,513,595 |
RGD:6480464 |
CTD |
| G |
LOC500300 |
similar to hypothetical protein MGC6835 |
|
multiple interactions |
ISO |
4 |
153,000,782 |
153,002,562 |
RGD:6480464 |
CTD |
| G |
Lpar3 |
lysophosphatidic acid receptor 3 |
|
multiple interactions |
ISO |
2 |
244,431,789 |
244,510,815 |
RGD:6480464 |
CTD |
| G |
Lpar3 |
lysophosphatidic acid receptor 3 |
|
decreases expression |
ISO |
2 |
244,431,789 |
244,510,815 |
RGD:6480464 |
CTD |
| G |
Lum |
lumican |
|
increases expression |
ISO |
7 |
35,083,480 |
35,090,284 |
RGD:6480464 |
CTD |
| G |
Lxn |
latexin |
|
increases expression |
ISO |
2 |
157,310,036 |
157,315,905 |
RGD:6480464 |
CTD |
| G |
Maml3 |
mastermind like 3 (Drosophila) |
|
increases expression |
ISO |
2 |
140,574,982 |
140,740,461 |
RGD:6480464 |
CTD |
| G |
Maoa |
monoamine oxidase A |
|
multiple interactions |
ISO |
X |
17,678,960 |
17,745,908 |
RGD:6480464 |
CTD |
| G |
Map1b |
microtubule-associated protein 1B |
|
increases expression |
ISO |
2 |
30,415,235 |
30,508,354 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk6 |
mitogen-activated protein kinase 6 |
|
increases expression |
ISO |
8 |
80,212,726 |
80,236,362 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Marcksl1 |
MARCKS-like 1 |
|
increases expression |
ISO |
5 |
148,669,499 |
148,672,337 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
decreases expression |
ISO |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mmd |
monocyte to macrophage differentiation-associated |
|
increases expression |
ISO |
10 |
78,664,115 |
78,692,402 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp10 |
matrix metallopeptidase 10 (stromelysin 2) |
|
increases expression |
ISO |
8 |
4,367,842 |
4,375,737 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
increases expression |
ISO |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mmp16 |
matrix metallopeptidase 16 |
|
increases expression |
ISO |
5 |
32,352,311 |
32,586,469 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
increases expression |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
increases expression |
ISO |
8 |
4,526,018 |
4,533,730 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mpzl1 |
myelin protein zero-like 1 |
|
decreases expression |
ISO |
13 |
81,321,155 |
81,357,929 |
RGD:6480464 |
CTD |
| G |
Mstn |
myostatin |
|
multiple interactions |
EXP |
9 |
45,426,831 |
45,431,658 |
RGD:6480464 |
CTD |
| G |
Mta1 |
metastasis associated 1 |
|
decreases expression |
ISO |
6 |
138,118,468 |
138,143,983 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
multiple interactions |
ISO |
2 |
181,399,482 |
181,403,640 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myh7 |
myosin, heavy chain 7, cardiac muscle, beta |
|
multiple interactions |
ISO |
15 |
33,072,928 |
33,094,595 |
RGD:6480464 |
CTD |
| G |
Myl2 |
myosin, light chain 2, regulatory, cardiac, slow |
|
multiple interactions |
ISO |
12 |
35,653,745 |
35,664,700 |
RGD:6480464 |
CTD |
| G |
Ncmap |
noncompact myelin associated protein |
|
multiple interactions |
ISO |
5 |
154,163,766 |
154,167,138 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
multiple interactions |
ISO |
5 |
5,197,891 |
5,275,776 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
multiple interactions |
ISO |
10 |
48,481,110 |
48,628,538 |
RGD:6480464 |
CTD |
| G |
Ndp |
Norrie disease (pseudoglioma) |
|
decreases expression |
ISO |
X |
17,416,946 |
17,441,393 |
RGD:6480464 |
CTD |
| G |
Neurl1a |
neuralized homolog 1A (Drosophila) |
|
increases expression |
ISO |
1 |
252,502,664 |
252,573,249 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
multiple interactions |
ISO |
10 |
82,582,766 |
82,588,269 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nova1 |
neuro-oncological ventral antigen 1 |
|
increases expression |
ISO |
6 |
66,193,472 |
66,320,240 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
multiple interactions |
ISO |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
ISO |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
decreases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
EXP |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
affects binding |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Ntn4 |
netrin 4 |
|
increases expression |
ISO |
7 |
30,717,988 |
30,832,378 |
RGD:6480464 |
CTD |
| G |
Nubp2 |
nucleotide binding protein 2 |
|
increases expression |
ISO |
10 |
14,131,309 |
14,134,994 |
RGD:6480464 |
CTD |
| G |
Ostm1 |
osteopetrosis associated transmembrane protein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
P2rx3 |
purinergic receptor P2X, ligand-gated ion channel, 3 |
|
multiple interactions |
EXP |
3 |
68,228,045 |
68,270,751 |
RGD:6480464 |
CTD |
| G |
P2ry14 |
purinergic receptor P2Y, G-protein coupled, 14 |
|
increases expression |
ISO |
2 |
148,501,968 |
148,503,616 |
RGD:6480464 |
CTD |
| G |
Paqr7 |
progestin and adipoQ receptor family member VII |
|
decreases expression |
ISO |
5 |
153,263,432 |
153,264,469 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pc |
pyruvate carboxylase |
|
decreases expression |
ISO |
1 |
207,112,853 |
207,212,737 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
multiple interactions |
ISO |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pemt |
phosphatidylethanolamine N-methyltransferase |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Per1 |
period circadian clock 1 |
|
multiple interactions |
EXP |
10 |
55,859,851 |
55,868,747 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
affects activity |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
decreases activity |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
decreases expression |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pibf1 |
progesterone immunomodulatory binding factor 1 |
|
decreases expression |
ISO |
15 |
82,881,953 |
83,056,944 |
RGD:6480464 |
CTD |
| G |
Pim1 |
pim-1 oncogene |
|
multiple interactions |
ISO |
20 |
7,817,403 |
7,821,800 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases expression |
ISO |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
multiple interactions |
EXP |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Pld1 |
phospholipase D1 |
|
increases expression |
ISO |
2 |
115,306,940 |
115,460,518 |
RGD:6480464 |
CTD |
| G |
Plk1s1 |
polo-like kinase 1 substrate 1 |
|
increases expression |
ISO |
3 |
135,488,158 |
135,598,982 |
RGD:6480464 |
CTD |
| G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
increases expression |
ISO |
8 |
97,525,279 |
97,623,152 |
RGD:6480464 |
CTD |
| G |
Plxdc2 |
plexin domain containing 2 |
|
increases expression |
ISO |
17 |
90,572,391 |
90,982,074 |
RGD:6480464 |
CTD |
| G |
Pold2 |
polymerase (DNA directed), delta 2, accessory subunit |
|
decreases expression |
ISO |
14 |
86,535,757 |
86,541,920 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppp1r1c |
protein phosphatase 1, regulatory (inhibitor) subunit 1C |
|
increases expression |
ISO |
3 |
62,519,426 |
62,622,517 |
RGD:6480464 |
CTD |
| G |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
|
increases expression |
ISO |
8 |
106,061,334 |
106,155,090 |
RGD:6480464 |
CTD |
| G |
Ppt2 |
palmitoyl-protein thioesterase 2 |
|
increases expression |
ISO |
20 |
4,225,630 |
4,234,653 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
multiple interactions |
ISO |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prodh |
proline dehydrogenase (oxidase) 1 |
|
decreases expression |
ISO |
11 |
84,905,060 |
84,922,229 |
RGD:6480464 |
CTD |
| G |
Prpsap1 |
phosphoribosyl pyrophosphate synthetase-associated protein 1 |
|
multiple interactions |
EXP |
10 |
106,582,381 |
106,604,072 |
RGD:6480464 |
CTD |
| G |
Psmc6 |
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
|
increases expression |
ISO |
15 |
21,217,367 |
21,239,320 |
RGD:6480464 |
CTD |
| G |
Ptbp2 |
polypyrimidine tract binding protein 2 |
|
increases expression |
ISO |
2 |
216,188,745 |
216,249,176 |
RGD:6480464 |
CTD |
| G |
Ptgds |
prostaglandin D2 synthase (brain) |
|
decreases expression |
ISO |
3 |
3,632,683 |
3,635,617 |
RGD:6480464 |
CTD |
| G |
Ptgir |
prostaglandin I2 (prostacyclin) receptor (IP) |
|
increases expression |
ISO |
1 |
77,234,538 |
77,236,921 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases expression |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
|
increases expression |
ISO |
1 |
17,328,563 |
17,752,200 |
RGD:6480464 |
CTD |
| G |
Rap1b |
RAP1B, member of RAS oncogene family |
|
increases expression |
ISO |
7 |
57,132,750 |
57,139,811 |
RGD:6480464 |
CTD |
| G |
Rap1b |
RAP1B, member of RAS oncogene family |
|
multiple interactions |
EXP |
7 |
57,132,750 |
57,139,811 |
RGD:6480464 |
CTD |
| G |
Rarg |
retinoic acid receptor, gamma |
|
decreases expression |
ISO |
7 |
140,991,447 |
141,014,108 |
RGD:6480464 |
CTD |
| G |
Rasgrp1 |
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
|
multiple interactions |
ISO |
3 |
103,371,879 |
103,433,010 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
increases activity |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1cc1 |
RB1-inducible coiled-coil 1 |
|
increases expression |
ISO |
5 |
13,301,486 |
13,365,398 |
RGD:6480464 |
CTD |
| G |
Reep6 |
receptor accessory protein 6 |
|
decreases expression |
ISO |
7 |
10,885,266 |
10,891,936 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rhog |
ras homolog family member G |
|
decreases expression |
ISO |
1 |
159,724,016 |
159,735,532 |
RGD:6480464 |
CTD |
| G |
Rnf146 |
ring finger protein 146 |
|
increases expression |
ISO |
1 |
29,255,138 |
29,265,731 |
RGD:6480464 |
CTD |
| G |
Rpl39 |
ribosomal protein L39 |
|
increases expression |
ISO |
X |
7,825,919 |
7,827,935 |
RGD:6480464 |
CTD |
| G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator candidate |
|
decreases expression |
ISO |
3 |
35,590,166 |
35,591,583 |
RGD:6480464 |
CTD |
| G |
Rps10 |
ribosomal protein S10 |
|
increases expression |
ISO |
20 |
5,849,327 |
5,853,893 |
RGD:6480464 |
CTD |
| G |
Rps10l1 |
ribosomal protein S10-like 1 |
|
increases expression |
ISO |
6 |
74,838,974 |
74,839,471 |
RGD:6480464 |
CTD |
| G |
RT1-DOb |
RT1 class II, locus DOb |
|
decreases expression |
ISO |
20 |
4,753,940 |
4,759,648 |
RGD:6480464 |
CTD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
multiple interactions |
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
decreases expression |
ISO |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
multiple interactions |
ISO |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
multiple interactions |
EXP |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
Sec23ip |
SEC23 interacting protein |
|
increases expression |
ISO |
1 |
187,999,550 |
188,042,408 |
RGD:6480464 |
CTD |
| G |
Sec62 |
SEC62 homolog (S. cerevisiae) |
|
increases expression |
ISO |
2 |
116,990,256 |
117,025,688 |
RGD:6480464 |
CTD |
| G |
Senp1 |
SUMO1/sentrin specific peptidase 1 |
|
increases expression |
ISO |
7 |
136,746,791 |
136,808,933 |
RGD:6480464 |
CTD |
| G |
Sept4 |
septin 4 |
|
decreases expression |
ISO |
10 |
75,871,422 |
75,880,878 |
RGD:6480464 |
CTD |
| G |
Serf2 |
small EDRK-rich factor 2 |
|
increases expression |
ISO |
3 |
108,255,260 |
108,258,848 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
decreases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpinf1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
|
decreases expression |
ISO |
10 |
62,713,441 |
62,739,444 |
RGD:6480464 |
CTD |
| G |
Sesn3 |
sestrin 3 |
|
increases expression |
ISO |
8 |
11,076,055 |
11,125,523 |
RGD:6480464 |
CTD |
| G |
Sfrp1 |
secreted frizzled-related protein 1 |
|
increases expression |
ISO |
16 |
73,030,458 |
73,067,304 |
RGD:6480464 |
CTD |
| G |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
|
increases expression |
ISO |
5 |
123,696,703 |
123,897,989 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
EXP |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
EXP |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
decreases expression |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc27a5 |
solute carrier family 27 (fatty acid transporter), member 5 |
|
decreases expression |
ISO |
1 |
72,924,630 |
72,935,223 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
multiple interactions |
EXP |
5 |
153,086,346 |
153,098,569 |
RGD:6480464 |
CTD |
| G |
Slc43a1 |
solute carrier family 43, member 1 |
|
decreases expression |
ISO |
3 |
68,049,296 |
68,090,034 |
RGD:6480464 |
CTD |
| G |
Slc7a4 |
solute carrier family 7 (orphan transporter), member 4 |
|
decreases expression |
ISO |
11 |
85,426,546 |
85,430,217 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
|
multiple interactions |
ISO |
8 |
108,012,829 |
108,098,561 |
RGD:6480464 |
CTD |
| G |
Slit3 |
slit homolog 3 (Drosophila) |
|
decreases expression |
ISO |
10 |
19,983,166 |
20,576,689 |
RGD:6480464 |
CTD |
| G |
Smurf2 |
SMAD specific E3 ubiquitin protein ligase 2 |
|
increases expression |
ISO |
10 |
96,170,590 |
96,269,365 |
RGD:6480464 |
CTD |
| G |
Snx12 |
sorting nexin 12 |
|
decreases expression |
ISO |
X |
89,180,623 |
89,302,886 |
RGD:6480464 |
CTD |
| G |
Snx2 |
sorting nexin 2 |
|
increases expression |
ISO |
18 |
48,642,904 |
48,684,466 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
multiple interactions |
EXP |
14 |
63,381,447 |
63,387,180 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
increases expression |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Spag1 |
sperm associated antigen 1 |
|
increases expression |
ISO |
7 |
71,699,341 |
71,759,373 |
RGD:6480464 |
CTD |
| G |
Sphk1 |
sphingosine kinase 1 |
|
multiple interactions |
EXP |
10 |
106,641,509 |
106,645,579 |
RGD:6480464 |
CTD |
| G |
Srpx |
sushi-repeat-containing protein, X-linked |
|
decreases expression |
ISO |
X |
24,833,279 |
24,904,349 |
RGD:6480464 |
CTD |
| G |
Srpx2 |
sushi-repeat-containing protein, X-linked 2 |
|
increases expression |
ISO |
X |
121,446,756 |
121,468,691 |
RGD:6480464 |
CTD |
| G |
St6galnac2 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
|
increases expression |
ISO |
10 |
106,793,126 |
106,811,346 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Stmn2 |
stathmin-like 2 |
|
increases expression |
ISO |
2 |
95,284,903 |
95,332,686 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
multiple interactions |
EXP |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
multiple interactions |
ISO |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Sumo1 |
SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) |
|
increases expression |
ISO |
9 |
58,212,538 |
58,242,760 |
RGD:6480464 |
CTD |
| G |
Svil |
supervillin |
|
increases expression |
ISO |
17 |
60,897,631 |
60,898,874 |
RGD:6480464 |
CTD |
| G |
Syngr1 |
synaptogyrin 1 |
|
decreases expression |
ISO |
7 |
118,328,188 |
118,351,610 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
multiple interactions |
ISO |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
multiple interactions |
EXP |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
multiple interactions |
EXP |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
multiple interactions |
EXP |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tek |
TEK tyrosine kinase, endothelial |
|
increases expression |
ISO |
5 |
115,047,195 |
115,196,172 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
decreases expression |
ISO |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
increases expression |
ISO |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Timm17a |
translocase of inner mitochondrial membrane 17 homolog A (yeast) |
|
increases expression |
ISO |
13 |
48,297,516 |
48,309,303 |
RGD:6480464 |
CTD |
| G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
|
decreases expression |
ISO |
2 |
155,312,341 |
155,339,357 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
increases expression |
ISO |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tlr7 |
toll-like receptor 7 |
|
decreases expression |
ISO |
X |
47,330,737 |
47,356,841 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects response to substance |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
increases expression |
ISO |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Trex1 |
three prime repair exonuclease 1 |
|
multiple interactions |
EXP |
8 |
114,071,508 |
114,072,509 |
RGD:6480464 |
CTD |
| G |
Trib2 |
tribbles homolog 2 (Drosophila) |
|
increases expression |
ISO |
6 |
39,474,243 |
39,496,718 |
RGD:6480464 |
CTD |
| G |
Uqcrb |
ubiquinol-cytochrome c reductase binding protein |
|
increases expression |
ISO |
7 |
67,958,363 |
67,963,730 |
RGD:6480464 |
CTD |
| G |
Uqcrb-ps1 |
ubiquinol-cytochrome c reductase binding protein, pseudogene 1 |
|
increases expression |
ISO |
1 |
90,807,565 |
90,807,900 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
increases expression |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Zfp36 |
zinc finger protein 36 |
|
multiple interactions |
ISO |
1 |
83,486,643 |
83,489,123 |
RGD:6480464 |
CTD |
| G |
Zfp422 |
zinc finger protein 422 |
|
increases expression |
ISO |
4 |
152,975,181 |
152,979,366 |
RGD:6480464 |
CTD |
Term paths to the root
|